Scholars@Duke

Reply to J. Schildmann et al.

Publication ,  Journal Article
El-Jawahri, A; LeBlanc, TW; Lee, SJ
Published in: J Clin Oncol
August 20, 2020
Published version (DOI) Link to item

Duke Scholars

Thomas William LeBlanc
Author Thomas William LeBlanc Medicine, Hematologic Malignancies and Cellular Therapy

Published In

J Clin Oncol

DOI

10.1200/JCO.20.01098

EISSN

1527-7755

Publication Date

August 20, 2020

Volume

38

Issue

24

Start / End Page

2815 / 2816

Location

United States

Related Subject Headings

  • Terminal Care
  • Palliative Care
  • Oncology & Carcinogenesis
  • Humans
  • Hematologic Neoplasms
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
El-Jawahri, A., LeBlanc, T. W., & Lee, S. J. (2020). Reply to J. Schildmann et al. J Clin Oncol, 38(24), 2815–2816. https://doi.org/10.1200/JCO.20.01098
El-Jawahri, Areej, Thomas W. LeBlanc, and Stephanie J. Lee. “Reply to J. Schildmann et al.” J Clin Oncol 38, no. 24 (August 20, 2020): 2815–16. https://doi.org/10.1200/JCO.20.01098.
El-Jawahri A, LeBlanc TW, Lee SJ. Reply to J. Schildmann et al. J Clin Oncol. 2020 Aug 20;38(24):2815–6.
El-Jawahri, Areej, et al. “Reply to J. Schildmann et al.” J Clin Oncol, vol. 38, no. 24, Aug. 2020, pp. 2815–16. Pubmed, doi:10.1200/JCO.20.01098.
El-Jawahri A, LeBlanc TW, Lee SJ. Reply to J. Schildmann et al. J Clin Oncol. 2020 Aug 20;38(24):2815–2816.

Published In

J Clin Oncol

DOI

10.1200/JCO.20.01098

EISSN

1527-7755

Publication Date

August 20, 2020

Volume

38

Issue

24

Start / End Page

2815 / 2816

Location

United States

Related Subject Headings

  • Terminal Care
  • Palliative Care
  • Oncology & Carcinogenesis
  • Humans
  • Hematologic Neoplasms
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences